Concepedia

Amarnath Sharma

AS

48

Publications

3.2K

Citations

28

H-Index

1993

Active since

Affiliations

Pfizer (United States)(Current)

Janssen (United States)

University at Buffalo, State University of New York

Springhouse

Roswell Park Comprehensive Cancer Center

Amarnath Sharma is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1993–2022

48

Publications

48

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Antoni Ribas, Luis H. Camacho, Gabriel Lopez‐Berestein et al. · Journal of Clinical Oncology · 2005 · 584 citations

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Paul Haluska, Heather M. Shaw, Gretchen N. Batzel et al. · Clinical Cancer Research · 2007 · 266 citations

Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes

Amarnath Sharma, Robert M. Straubinger · Pharmaceutical Research · 1994 · 213 citations

Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma

Martha Q. Lacy, Melissa Alsina, Rafaël Fonseca et al. · Journal of Clinical Oncology · 2008 · 160 citations · Full text

Pharmacokinetics and Safety of Duloxetine, a Dual‐Serotonin and Norepinephrine Reuptake Inhibitor

Amarnath Sharma, Mark J. Goldberg, Benito J. Cerimele · The Journal of Clinical Pharmacology · 2000 · 146 citations

Rows per page

1–5 of 48